Literature DB >> 3900841

Clinical, biochemical, and ovarian morphologic features in women with acanthosis nigricans and masculinization.

A Dunaif, A R Hoffman, R E Scully, J S Flier, C Longcope, L J Levy, W F Crowley.   

Abstract

Nine women with acanthosis nigricans and masculinization, who did not appear to have any of the reported syndromes associated with acanthosis nigricans, were studied to characterize the clinical, biochemical, and ovarian morphologic features of their disorders. These patients had the clinical and biochemical profiles of polycystic ovarian disease. All acanthosis nigricans subjects had significant insulin resistance when insulin binding to both circulating monocytes and erythrocytes was compared to the control subjects. Microscopic examination of the ovaries revealed no evidence of recent normal ovulation, sclerosis of the ovarian cortex, follicle cysts, and stromal hyperthecosis. The authors conclude that ovarian stromal hyperthecosis and insulin resistance are consistent findings in the present type of patient. This study provides further evidence supporting a relationship between insulin resistance and human ovarian function.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3900841

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  8 in total

1.  Perspectives in Polycystic Ovary Syndrome: From Hair to Eternity.

Authors:  Andrea Dunaif
Journal:  J Clin Endocrinol Metab       Date:  2016-02-23       Impact factor: 5.958

Review 2.  Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.

Authors:  Daniel A Dumesic; Sharon E Oberfield; Elisabet Stener-Victorin; John C Marshall; Joop S Laven; Richard S Legro
Journal:  Endocr Rev       Date:  2015-10       Impact factor: 19.871

Review 3.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

4.  Predictors of insulin resistance and metabolic complications in polycystic ovarian syndrome in an eastern Indian population.

Authors:  Anindya Dasgupta; Aparna Khan; Ushasi Banerjee; Mrinalkanti Ghosh; Mrinal Pal; Kanika M Chowdhury; Sayantan Dasgupta
Journal:  Indian J Clin Biochem       Date:  2012-09-14

5.  Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome.

Authors:  A Dunaif; M Graf
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

6.  State of the Art Review: Emerging Therapies: The Use of Insulin Sensitizers in the Treatment of Adolescents with Polycystic Ovary Syndrome (PCOS).

Authors:  David H Geller; Danièle Pacaud; Catherine M Gordon; Madhusmita Misra
Journal:  Int J Pediatr Endocrinol       Date:  2011-08-26

Review 7.  The polycystic ovary syndrome: an update on metabolic and hormonal mechanisms.

Authors:  R Dumitrescu; C Mehedintu; I Briceag; V L Purcarea; D Hudita
Journal:  J Med Life       Date:  2015 Apr-Jun

Review 8.  Genetic Rodent Models of Obesity-Associated Ovarian Dysfunction and Subfertility: Insights into Polycystic Ovary Syndrome.

Authors:  Isabel Huang-Doran; Stephen Franks
Journal:  Front Endocrinol (Lausanne)       Date:  2016-06-07       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.